期刊文献+

口腔颌面部恶性肿瘤SUVmax的诊断价值 被引量:3

下载PDF
导出
摘要 目的:探讨SUVmax(maximum standardized uptake value)应用于口腔颌面部良恶性病变的诊断阈值及比较鳞癌、腺源性癌、肉瘤、结外型淋巴瘤之间SUVmax值的差异;方法:收集2009-2011年在解放军307医院行口腔颌面部病灶PET/CT(positron emission tomography-computed tomography)检查且有病理确诊的患者资料。SUVmax的良恶性诊断阈值采用ROC曲线分析;口腔面部鳞癌、腺源性癌、肉瘤、结外型淋巴瘤SUVmax值的差异比较采用t检验;结果:ROC曲线下面积为0.983,SUVmax值为2.00,灵敏度为1.00,SUVmax值为3.65,(1-特异度)为0.00。鳞癌腺源性、癌肉瘤、淋巴瘤的SUVmax值分别为10.45±4.61、9.84±7.48、9.58±5.77、14.71±9.24;鳞癌、腺源性癌、肉瘤、结外型淋巴瘤之间比较差异无统计学意义(P>0.05);结论 :SUVmax值不能作为判断恶性肿瘤病理类型的依据;SUVmax≤2.00为良性病变诊断阈值,SUVmax≥3.65为恶性病变诊断阈值。
出处 《实用医学杂志》 CAS 北大核心 2014年第14期2279-2280,共2页 The Journal of Practical Medicine
关键词 口腔 肿瘤 诊断
  • 相关文献

参考文献8

  • 1朱峥嵘,罗灿华,袁建伟,冯彦林,廖珊.^(18)F-FDG PET/CT在甲状腺肿瘤原发灶中的诊断价值[J].实用医学杂志,2011,27(4):634-636. 被引量:6
  • 2张洋,张宁,冯彦林,张国义.^(18)F-脱氧葡萄糖-正电子发射型体层摄影术显像诊断鼻咽癌放疗后残留病灶的价值[J].实用医学杂志,2007,23(7):969-970. 被引量:4
  • 3Kubicek JG, Champ C, Fogh S, et al. FDG-PET staging and importance of lymph node SUV in head and neck cancer [J]. Head Neck Oncol, 2010,16(2) : 19-22.
  • 4Nakamura S, Okochi K, Kurabayashi T. Dual-time-point fluorodeoxyglucose positron emission tomography for diagnosis of cervical lymph node metastases in patients with head and neck squamous cell carcinoma [J]. J Comput Assist Tomogr, 2011, 35(2) :303-307.
  • 5Matsubara R, Kawano S, Chikui T, et al. Standardized Uptake Value of F-18 FDG PET with Nodal Size in the Diagnosis of Cervical Lymph Node Metastasis of Oral Squamous Cell Carcinoma [J]. Acad Radiol, 2012,19(6) :708-717.
  • 6Haerle KS, Huber GF, Hany TF, et al. Is there a correlation between lSF-FDG-PET standardized uptake value,T-classi? cation, histological grading and the anatomic subsites in newly diagnosed squamous cell carcinoma of the head and neck? [J]. Eur Arch Otorhinolaryngol, 2010,267 (10) : 1635-1640.
  • 7Hadiprodjo D, Ryan T, Truong MT, et al. Parotid Gland Tumors: Preliminary Data for the Value of FDG PET/CT Diagnostic Parameters [J]. Am J Roentgenol, 2012,198 (2): 185-190.
  • 8Joo YH, Yoo IeR, Cho K J, et al. Standardized Uptake Value and Resection Margin Involvement Predict Outcomes in pN0 Head and Neck Cancer [J]. Otolaryngol Head Neck Surg, 2013, 149(5) :721-726.

二级参考文献11

  • 1潘辉林,宋慧胜,冯正富,黄岩.放疗加化疗综合治疗中晚期鼻咽癌40例疗效观察[J].实用医学杂志,2005,21(11):1194-1196. 被引量:2
  • 2林映如,陈应瑞,李伟雄.FDG-PET判断鼻咽癌放疗后复发的临床价值[J].实用医学杂志,2005,21(20):2269-2270. 被引量:7
  • 3Chisin R,Macapinlac H A.The indications of FDG-PET in neck oncology[J].Radiol Clin North Am,2000,38(5):999-1012.
  • 4Dong M J,Liu Z F,Zhao K,et al.Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan:a meta-analysis[J].Nucl Med Commun,2009,30(8):639-650.
  • 5Kaneko K,Abe K,Baba S,et al.Detection of residual lymph node metastases in high-risk papillary thyroid cancer patients receiving adjuvant I-131 therapy:the usefulness of F-18 FDG PET/CT[J].Clin Nucl Med,2010,35(1):6-11.
  • 6Mitchell J C,Grant F,Evenson A R,et al.Preoperative evaluation of thyroid nodules with 18FDG-PET/CT[J].Surgery,2005,138(6):1166-1174.
  • 7Munley M T.Maltimodality nuclear medicine imaging in threedimensional radiation treatment planning for lung cancer:Challenge and prospects[J].Lung Cancer,1999,23(2):105-114.
  • 8Mitsuhashi N,Hayakawa K,Hasegawa M,et al.Clinical FDG-PET in diagnosis and evaluation of radiation response of patients with nasopharyneal tumor[J].Anticancer Ros,1998,23(18):2827-2832.
  • 9李立伟,金泉,马璐娜,刘京璇.鼻咽癌放射治疗后FDG PET显像的临床价值[J].中华放射肿瘤学杂志,2001,10(1):1-3. 被引量:18
  • 10陈应瑞,辜梅新,李伟雄,潘燚.FDG PET判断鼻咽癌放疗后鼻咽病灶残留的临床价值[J].癌症,2002,21(6):651-653. 被引量:23

共引文献8

同被引文献22

  • 1Ronnett BM, Zahn CM, Kurman RJ, et al. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcino matosis. A clinicopathologic analysis of 109 cases with em- phasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei"[J]. Am J Surg Pathol, 1995,19(12) :1390-1408.
  • 2Carr NJ, Finch J, Ilesley IC, et al . Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases [J]. J Clin Pathol, 2012,65(10) :919-923.
  • 3Taflampas P, Dayal S, Chandrakumaran K, et al . Pre-opera- tive tumour marker status predicts recurrence and survival after complete eytoreduetion and hyperthermic intraperitoneal chemo- therapy for appendiceal Pseudomyxoma Peritonei: Analysis of 519 patients[J]. Fur J Surg Oncol, 2014,40(5) :515 -520.
  • 4Diop AD, Fontarensky M, Montoriol PF, et al . CT imaging of peritoneal careinomatosis and its mimics E J]- Diagn IntervImaging, 2014,95(9) :861-872.
  • 5Buy JN. Magnetic resonance imaging of pseudomyxoma peritonei [J]. Eur J Radiol, 1989,9(2) :115-118.
  • 6Passot G, Glehen O, Pellet O, et al . Pseudomyxoma peritonei: role of 18 F-FDG PET in preoperative evaluation of pathological grade and potential for complete cytoreduction[J]. Eur J Surg Oncol, 2010,36(3) :315-323.
  • 7Dubreuil J. FDG-PET/ceCT is useful to predict recurrence of Pseudomyxoma peritonei[J]. Eur J Nucl ivied Mol Imaging, 2016,43(9) :1630-1637.
  • 8孙彦,陈文,崔立刚,王金锐.腹膜假性黏液瘤的声像图特征及超声诊断价值[J].中华医学超声杂志(电子版),2010,7(1):28-31. 被引量:10
  • 9卢晓林,刘锐,孙方方,文建民.PET-CT显像在口腔颌面部恶性肿瘤患者颈淋巴结转移诊断中的价值[J].江苏医药,2014,40(8):908-910. 被引量:5
  • 10刘科星.口腔颌面部恶性肿瘤伴肺转移放疗患者的临床护理[J].中华肺部疾病杂志(电子版),2014,7(3):105-106. 被引量:4

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部